Intriguingly and similarly to our results, targeting HGF/MET in combination with tumor irradiation (but not tumor irradiation alone) prolonged survival in the SMA-560 glioma model but did not affect radiosensitivity in vitro35. The gene discussed is MET; the disease is central nervous system cancer.